Epidemiology of Soft Tissue Sarcoma and Bone Sarcoma inItaly: Analysis of Data from 15 Population-Based Cancer Registries

Author:

Fabiano Sabrina1,Contiero Paolo2,Barigelletti Giulio1,D’Agostino Anna1,Tittarelli Andrea1,Mangone Lucia3,Bisceglia Isabella3,Bongiorno Salvatore4,De Lorenzis Lucia Elena5,Mazzoleni Guido6,Castaing Marine7,Intrieri Teresa8,Puppo Antonella9,Carrozzi Giuliano10,Sini Giovanna Maria11,Fontanili llaria12,Boschetti Lorenza13,Tumino Rosario14,Bella Francesca15,Fanetti AnnaClara16,Castelli Maurizio4,Ardizzone Antonio5,Vittadello Fabio6,Sciacca Salvatore7,Manneschi Gianfranco8,Casella Claudia9,Cirilli Claudia10,Pala Filomena11,Michiara Maria12,Migliazza Simona13,Ferrari Francesca3,Spata Eugenia14,Dinaro Ylenia15,Cometti Ivan16,Maghini Anna1,Tagliabue Giovanna1ORCID

Affiliation:

1. Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy

2. Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy

3. Epidemiology Unit, L’Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

4. Aosta Valley Health Authorities Department of Public Health, Cancer Registry, Aosta, Italy

5. Cancer Registry Local Health Unit Brindisi-Section of the Puglia Cancer Registry, Brindisi, Italy

6. Cancer Registry of South Tyrol, South Tyrol, Italy

7. Integrated Cancer Registry of Catania-Messina-Siracusa-Enna, Department of Hygiene and Public Health, Università di Catania, Catania, Italy

8. Clinical Epidemiology, Institute for Study and Cancer Prevention, Florence, Italy

9. Liguria Cancer Registry, IRCCS Ospedale Policlinico San Martino, Genova, Italy

10. Epidemiology Unit, AUSL of Modena, Modena, Italy

11. Nuoro Cancer Registry-ATS Sardegna (ASSL Nuoro), Nuoro, Italy

12. Parma Cancer Registry, Oncology Unit, L’Azienda Ospedaliera-Universitaria di Parma, Parma, Italy

13. Cancer Registry Epidemiology Monitoring Unit Public Health Agency of Pavia, Pavia, Italy

14. Cancer Registry and Histopathology Department, Provincial Health Authority (ASP), Ragusa, Italy

15. Cancer Registry of Siracusa Province, Health Unit of Siracusa Province, Siracusa, Italy

16. Epidemiology Unit, Health Protection Agency, Sondrio, Italy

Abstract

Sarcomas are a heterogeneous group of rare cancers of mesenchymal origin. In this study, we provide updated, world age-standardised incidence rate (ASR) and European age-standardised incidence rate for malignant soft tissue sarcoma (ICD-O-3 topographic code C47–C49) and bone sarcoma (C40, C41) in Italy, by area (north, centre, and south) and by cancer registry. We also assess morphology in relation to site and area and assess metastases at diagnosis. We analysed 1,112 cases, with incidence 2009–2012, provided by 15 cancer registries (CRs) affiliated to the Association of Italian Cancer Registries (AIRTUM). Overall, ASR was 1.7/100,000/year for soft tissue sarcoma and 0.7 for bone sarcoma. Central Italy had the highest (2.4) ASR and south Italy had the lowest (1.6) ASR for soft tissue sarcoma. Central Italy had the highest (1.1) ASR and north Italy had the lowest (0.7) ASR for bone sarcoma. By CR, ASRs ranged from 1.1 to 2.6 for soft tissue sarcoma and from 0 to 1.4 for bone sarcoma. The most frequent soft tissue sarcomas were sarcoma not otherwise specified (NOS) (29.4%) and liposarcoma (22.2%); the most common bone sarcoma was chondrosarcoma (37.6%). Soft tissue sarcomas occurred most frequently (35.6%) in lower limb connective tissue; bone sarcomas arose mainly (68.8%) in long bones. The frequencies of morphologies arising at different sites varied considerably by Italian area; for example, 20% of hemangiosarcomas occurred in the head and neck in south Italy with 17% at this site in the centre and 6% in the north. For soft tissue sarcoma, the highest ASRs of 2.6 and 2.4 contrast with the lowest ASRs 1.1 and 1.3, suggesting high-risk hot spots that deserve further investigation. The marked variations in morphology distribution with site and geography suggest geographic variation in risk factors that may also repay further investigation particularly since sarcoma etiology is poorly understood.

Publisher

Hindawi Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3